Therachon anuncia que apraglutida ha recibido la designación de medicamento huérfano en Europa

By In The News
March 22, 2019 in The Headlines

Recommended Posts

In The News

Posted March 22, 2019

- Share

Posted March 22, 2019

- Therachon anuincia que apraglutida ha recibido la designación de medicamento huérfano en Europea para el tratamiento del síndrome del intestino corto La apraglutida, que se administra una vez por semana, es un potente fármaco de primera categoría para el tratamiento del síndrome del...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219989
2. Jaydee
  16831
3. Kip Powick
  12225
4. deicer
  12196
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.3k
- Total Posts
  
  559k

Sign In

Therachon anuncia que apraglutida ha recibido la designación de medicamento huérfano en Europa

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support